Advanced search
Publication Cover
International Review of Psychiatry Volume 14, 2002 - Issue 2: Anxiety disorders in children and adolescents
Submit an article Journal homepage
87
Views
11
CrossRef citations to date
0
Altmetric
Research Article

The pharmacological treatment of childhood anxiety disorders

John T. Walkup Johns Hopkins Hospital, Baltimore, Maryland, USA
,
Michael J. Labellarte Johns Hopkins Hospital, Baltimore, Maryland, USA
&
Golda S. Ginsburg Johns Hopkins Hospital, Baltimore, Maryland, USA
Pages 135-142 | Published online: 11 Jul 2009

  • ADAA/NIMH (1999). Conference on treating anxiety disorders in youth: current problems and future solutions. Anxiety Disorders Association of America.
  • ALBANO, A.M., MARTEN, P.A., HOLT, C.S., HEIMBERG, R.G. & BARLOW, D.H. (1995). Cognitive-behavioral group treatment for social phobia in adolescents: a preliminary study. Journal of Nervous Mental Disease, 183, 649-656.
  • ALDERMAN, J., WOLKOW, R., CHUNG, M., et al (1998). Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacoldnetics, tolerability, and efficacy. Journal of American Academy of Child and Adolescent Psychiatry, 37, 386-394.
  • AMERICAN PSYCHIATRIC ASSOCIATION (1980). Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Press.
  • AMERICAN PSYCHIATRIC ASSOCIATION (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press.
  • AMERICAN PSYCHIATRIC ASSOCIATION (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text revision. Washington, DC: American Psychiatric Press.
  • BARRIOS, B.A. & HARTMAN, O.P. (1997). Fears and anxieties. In: EJ. Mash & L.G. TERDAL (Eds), Assessment of childhood disorders, 3rd ed. New York: Guilford Press.
  • BARRETT, P.M. (1998). Evaluation of cognitive-behavioral group treatments for childhood anxiety disorders. Journal of Clinical Child Psychology, 27, 459-468.
  • BARRETT, P.M., DADDS, M.M., RAPEE, R.M. & RYAN, S.M. (1996). Family intervention for childhood anxiety. Journal of Consulting Clinical Psychology, 64, 333-342.
  • BEIDEL, D.C. (1991). Determining the reliability psychophysiological assessment in childhood anxiety. Journal of Anxiety Disorders, 5, 139-150.
  • BEIDEL, D.C., NEAL, A.M. & LEDERER, A.S. (1991). The feasibility and validity of a daily diary for the assessment of anxiety in children. Behavior Therapy, 22, 505-517.
  • BELL-DOLAN, D. & BRAZEAL, T.J. (1993). Separation anxiety disorder, overanxious disorder, and school refusal. Child and Adolescent Psychiatric Clinics of North America, 2, 563-580.
  • BERNEY, T., KOLVIN, I., BHATE, R.F., et al (1981). School phobia: a therapeutic trial with clomipramine and short term outcome. British Journal of Psychiatry, 138,110-118.
  • BERNSTEIN, G.A., GARFINKEL, B.D. & BORCHARDT, C.M. (1990). Comparative studies of pharmacotherapy for school refusal. Journal of American Academy of Chad and Adolescent Psychiatry, 29, 773-781.
  • BERNSTEIN, G.A., HEKTNER, J.M., BORCHARDT, C.M. & MCMILLAN, M.H. (2001). Treatment of school refusal: one-year follow-up. Journal of American Academy of Child and Adolescent Psychiatry, 40, 206-213.
  • BERNSTEIN, G.A., BORCHARDT, C.M., PERWEIN, A.R., et al. (2000). Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. Journal of American Academy of Child and Adolescent Psychiatry, 39, 276-283.
  • BIRMAHER, B., BRENT, D.A., CHIAPPETTA, L., BRIDGE, J., MONGA, S. & BAUGHER, M. (1999). Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. Journal of American Academy of Child and Adolescent Psychiatry, 38,1230-1236.
  • BIRMAHER, B., KHETARPAL, S., BRENT, D., CULLY, M., BALACH, L., KAUFMAN, J. & MCKENZIE-NEER, S. (1997). The screen for child anxiety related emotional disorders (SCARED): scale construction and psychometric characteristics. Journal of American Academy of Chad and Adolescent Psychiatry, 36, 545-553.
  • BIRMAHER, B., WATERMAN, G.S., RYAN, N., CULLY, M., BALACH, L., INGRAM, J., BRODSKY, M. (1994). Fluoxetine for childhood anxiety disorders. Journal of American Academy of Child and Adolescent Psychiatry, 33(7), 993-999.
  • BLACK, B. & UHDE, T.W. (1994). Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. Journal of American Academy of Child and Adolescent Psychiatry, 33, 1000-1006.
  • COBHAM, V.E., DADDS, M.R. & SPENCE, S.H. (1998). The role of parental anxiety in the treatment of childhood anxiety. Journal of Consulting Clinical Psychology, 66, 893-905.
  • COFFEY, B. (1993). Review and update: benzodiazapines in childhood and adolescence. Psychiatric Annals, 23, 332-339.
  • COFFEY, B., SHADER, R. & GREENBLATT, D. (1983). Pharmacokinetics of benzodiazapines and psychostimulants in children. Journal of Clinical Psychopharmacology, 3, 82-87.
  • COYLE, J.T. (2001), Drug treatment of anxiety disorders in children. New England Journal of Medicine, 344, 1326-1327.
  • CYTRYN, L., GILBERT, A. & EISENBERG, L. (1960). The effectiveness of tranquilizing drugs plus supportive psychotherapy in treating behavior disorders of children: a double blind study of eighty outpatients. American Journal of Orthopsychiatry, 30, 113-128.
  • DANNON, P.N., SASSON, Y., HIRSCHMANN, S., IANCU, I., GRUNHAUS, L.J. & ZOHAR, J. (2000). Pindolol augmentation in treatment-resistant obsessive compulsive disorder a double-blind placebo controlled trial. European Neuropsychopharmacology, 10(3), 165-169.
  • DEHANN, E., HOOGDUIN, K.A.L., BUITELAAR, J.K. & KEIJSERS, G.P.J. (1998). Behavior therapy versus clomipramine for the treatment of OCD in children and adolescents. Journal of American Academy of Chad and Adolescent Psychiatry, 37, 1022-1029.
  • DERIVAN, A., AGUIAR, L., UPTON, G.V., et al (1995). Poster presented at the 42nd annual meeting of the American Academy of Child and Adolescent Pychiatry, New Orleans, 17-22 October. Scientific Proceedings.
  • DEVEAUGH-GEISS, J., MOROZ, B. & BIEDERMAN, J. (1992). Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder-a multicenter trial. Journal of American Academy of Child and Adolescent Psychiatry, 31, 45-49.
  • EDELBROCK, C. & COSTELLO, A. (1984). Structured psychiatric interviews for children and adolescents. In: G. GOLDSTEIN & M. HERSEN (Eds), Handbook of psychological assessment (pp. 276-290). New York: Pergamon Press.
  • EMSLIE, G.J., WAGNER, K., RIDDLE, M., BIRMAHER, B., GELLER, B., ROSENBERG, D., GALLAGHER, D. & CARPENTER, D. (2000). Efficacy and safety of paroxetine in juvenile OCD. Poster presented at the 47th annual meeting of the American Academy of Child and Adolescent Pychiatry in New York, 24-29 October. Scientific Proceedings.
  • EMSLIE, G.J., RUSH, A.J., WEINBERG, W.A., et al (1997). A double-blind, placebo controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037.
  • EISENBERG, L., GILBERT, A., CYTRYN, L. & MOLLING, PA. (1961). The effectiveness of psychotherapy alone and in conjunction with perphenazine or placebo in the treatment of neurotic and hyperkinetic children. American Journal of Psychiatry, 117, 1088-1093.
  • FAIRBANKS, J.M., PINE, D.S., TANCER, N.K. & DUMMIT, E.S., 3RD, KENTGEN, L.M., MARTIN, J., ASCHE, B.K., KLEIN, R.G. (1997). Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 7(1), 17-29.
  • FINCH, A.J., LIPOVSKY, J.A. & CASAT, C.D. (1989). Anxiety and depression in children and adolescents: negative affectivity or separate constructs? In: P.C. KENDALL & D. WATSON (Eds), Anxiety and depression: distinctive and overlapping features (pp. 171-196). San Diego, CA: Academic Press.
  • FINDLING, R.L., PRESKORN, S.H., MARCUS, R.N., et al (2000). Nefazodone pharmacokinetics in depressed children and adolescents. Journal of American Academy of Child and Adolescent Psychiatry, 39, 1008-1016.
  • FINDLING, R.L., REED, M.D., MYERS, C., et al, (1999). Paroxetine pharmacokinetics in depressed children and adolescents. Journal of American Academy of Chad and Adolescent Psychiatry, 38, 952-959.
  • FLAMENT, M., RAPOPORT, J.L., BEG, C., et al (1985). Clomipramine treatment of childhood obsessivecompulsive disorder. Archives of General Psychiatry, 42, 977-988.
  • FRANKLIN, M.E., KOZAK, M.J., CASHMAN, L.A., COLES, M.E., RHEINGOLD, A.A. & FOA, E.B. (1998). Cognitivebehavioral treatment of pediatric obsessive-compulsive disorder an open clinical trial. Journal of American Academy of Child and Adolescent Psychiatry, 37, 412-419.
  • FROMMER, E.A. (1967). Treatment of childhood depression with antidepressant drugs. British Medical Journal, 1(542), 729-732.
  • FYER, A., MANNUZZA, S., CHAPMAN, T., MARTIN, L. & KLEIN, D. (1995). Specificity in familial aggregation of phobic disorders. Archives of General Psychiatry, 52, 564-573.
  • GELLER, D.A., HOOG, S.L. & HEILIGENSTEIN , J.H. (2001). Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. Journal of American Academy of Child and Adolescent Psychiatry, 40, 773-779.
  • GINSBURG, G.S., SILVERMAN, W.K. & KURTINES, W.M. (1995). Family involvement in treating children with phobic and anxiety disorders: a look ahead. Clinical Psychology Review, 15, 457-473.
  • GITTLEMAN-KLEIN, R. & KLEIN, D (1971). Controlled imipramine treatment of school phobia. Archives of General Psychiatry, 25, 204-207.
  • GITTLEMAN-KLEIN, R. & KLEIN, D. (1973). School phobia: diagnostic considerations in light of imipramine effects. Journal of Nervous Mental Disease, 156,199-215.
  • GLENNON, B. & WEISZ, J.R. (1978). An observational approach to the assessment of anxiety in young children. Journal of Consulting Clinical Psychology, 46, 1246-1257.
  • GOULD, R.A., OTTO, M.W., POLLACK, M.P. & YAP, L, (1997a). Cognitive-behavioral and pharmacological treatment of generalized anxiety disorder a preliminary meta-analysis. Behavior Therapy, 28, 285-305.
  • GOULD, R.A., BUCKMINSTER, S., POLLACK, M.H., OTTO, M.W. & YAP, L. (1997b). Cognitive-behavioral and pharmacological treatment for social phobia: a metaanalysis. Clinical Psychology: Science and Practice, 4, 291-306.
  • GRAAE, F., MILNER, J., RIZOTTO, L. & KLEIN, R.G. (1994). Clonazepam in childhood anxiety disorders. Journal of American Academy of Chad and Adolescent Psychiatry, 33, 372-376.
  • GURLEY, D., COHEN, P., PINE, D.S. & BROOK, J. (1996). Discriminating anxiety an depression in youth: a role for diagnostic criteria. Journal of Affective Disorders, 39(3), 191-200.
  • GUTTERREZ, M., CHOU, T.C., TIESO, P., et al (2000) The pharmacokinetics of citalopram in adolescents and adults with depression. Poster presented at the 47th annual meeting of the American Academy of Child and Adolescent Psychiatry in New York, 24-29 October. Scientific Proceedings.
  • HAYWARD, C., VARADY, S., ALBANO, A.M., et al (2000). Cognitive-behavioral group therapy for social phobia in female adolescents: results of a pilot study. Journal of American Academy of Child and Adolescent Psychiatry, 39, 721-726.
  • HIRSCHMANN, S., DANNON, P.N., IANCU, I., DOLBERG, O.T., ZOHAR, J. & GRUNHAUS, L. (2000). Pindolol augmentation in patients with treatment-resistant panic disorder a double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 20(5), 556-559.
  • HUGHES, C.W., PRESKORN, S.H., WRONA, M., HASSANEIN, R. & TUCKER, S. (1990). Followup of adolescents initially treated for prepubertal-onset major depressive disorder with Imipramine. Psychopharmacology Bulletin 26, 244248.
  • KAUFMAN, J., BIRMAHER, B., BRENT, D., et al (1996). Schedule for affective disorders and schizophrenia for school-aged children-present and lifetime version (KSADS-PL): initial reliability and validity data. Journal of American Academy of Child and Adolescent Psychiatry, 36(7), 980-988.
  • KENDALL, P.C. (1994). Treating anxiety disorders in children: results of a randomized clinical trial. Journal of Consulting Clinical Psychology, 62, 200-210.
  • KENDALL, P.C. & BRADY, E.U. (1995). Comorbidity in the anxiety disorders of childhood. In: K.D. CRAIG & K.S. DOBSON (Eds), Anxiety and depression in adults and children. Newbury Park, CA: Sage Publications.
  • KENDALL, P.C. & SOUTHAM-GEROW, M.A. (1996). Longterm follow-up of a cognitive-behavioral therapy for anxiety-disordered youths. Journal of Consulting Clinical Psychology, 64, 724-730.
  • KENDALL, P.C., FLANNERY-SCHROEDER, E., PANICHELLIMINDEL, S.M., SOUTHAM-GEROW, M., HENIN, A. & WARMAN, A. (1997). Therapy for youths with anxiety disorders: a second randomized clinical trial. Journal of Consulting Clinical Psychology, 65, 366-380.
  • KELLER, M.B., RYAN, N.D., STROBER, M., KLEIN, R.G., KUTCHER, S.P., BIRMAHER, B., HAGINO, O.R., KOPLEWICZ, H., CARLSON, G.A., CLARKE, G.N., EMSLIE, G.J., FEINBERG, D., GELLER, B., KUSUMAKAR, V., PAPATHEODOROU , G., SACK, W.H., SWEENEY, M., WAGNER, K.D., WELLER, E.B., WINTERS, N.C., OAKES, R. & MCCAFFERTY, J.P. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of American Academy of Chad and Adolescent Psychiatry, 40(7), 762-772.
  • KING, N.J., OLLENDICK, T.H. & GULLONE, E. (1991). Negative affectivity in children and adolescents: relations between anxiety and depression. Clinical Psychology Review, 11, 441-459.
  • KLEIN, R.G., KOPELWICZ, H.S. & KANNER, A. (1992). Imipramine treatment in children with separation anxiety disorder. Journal of American Academy of Chad and Adolescent Psychiatry, 31, 21-28.
  • KOREIN, J., FBH, B., SHAPIRO, T., GERNER, E.W. & LEVIDOW, T. (1971). WWG and behavioral affects of drug therapy in children. Chlorpromazine and diphenhydramine. Archives of General Psychiatry, 24, 552-563.
  • LABELLARTE, M.J., GINSBERG, G.S. & RIDDLE, M.A. (1999). The treatment of anxiety disorders in children and adolescents. Biological Psychiatry, 46, 1567-1578.
  • LAST, G.G., HANSEN, C. & FRANCO, N. (1992). Anxious children in adulthood: a prospective study of adjustment. Journal of American Academy of Chad and Adolescent Psychiatry, 36, 645-652.
  • LAST, G.G., HERSEN, M., KAZDIN, A., ORVASCHEL, H. & PERRIN, S. (1991). Anxiety disorders in children and their families. Archives of General Psychiatry, 48, 928-934.
  • LECKMAN, J.F., RIDDLE, M.A., HARDIN, M.T., ORT, S.I., SWARTZ, K.L., STEVENSON, J. & COHEN, D.J. (1989). The Yale Global Tic Severity Scale (YGTSS): initial testing of a clinical-rated scale of tic severity. Journal of American Academy of Child and Adolescent Psychiatry, 28, 566-573.
  • LEONARD, H.L., MARCH, J., RICKLER, K.C. (1997). Pharmacology of selective serotonin reuptake inhibitors in children and adoescents. Journal of American Academy of Child and Adolescent Psychiatry, 36, 725-736.
  • LEONARD, H.L., SWEDO, S.E., RAPAPORT, J.L., et al (1989). Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents: a double-blind crossover comparison. Archives of General Psychiatry, 46, 1088-1092.
  • MARCH, J.S., MULLE, K. & HERBEL, B. (1994). Behavioral therapy for children and adolescents with obsessivecompulsive disorder: an open trial with a protocol driven package. Journal of American Academy of Child and Adolescent Psychiatry, 33, 333-341.
  • MARCH, J.S., PARKER, J., SULLIVAN, K., STALLINGS, P. & CONNERS, C.K. (1997). The multidimensional anxiety scale for children (MASC): actor structure, reliability, and validity. Journal of American Academy of Chad and Adolescent Psychiatry, 36, 554-565.
  • MARCH, J.S., BIEDERMAN, J., WOLKOW, R., SAFFERMAN, A., MARDEKIAN, J., COOK, E.H., et al. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder a multicenter randomized controlled trial. JAMA, 280, 1752-1756.
  • MELAMUD, E.G. & SEIGEL, L.J. (1975). Reductions of anxiety in children feeing hospitalization and surgery by use of filmed modeling. Journal of Consulting Clinical Psychology, 43, 511-521.
  • MENDEL, J.G. & KLEIN, D.F. (1969) Anxiety attacks with subsequent agoraphobia. Comprehensive Psychiatry, 10(3), 190-195.
  • MENDLOWITZ, S.L., MANASSIS, K., BRADLEY, S., SCAPILLATO, D., MIEZITIS, S. & SHAW, B. (1999). Cognitivebehavioral group treatments in childhood anxiety disorders: the role of parental involvement. Journal of American Academy of Child and Adolescent Psychiatry, 38, 1223-1229.
  • MILIN, R.P., SIMEON, J. & SPENST, W. (1999) Double-blind study of paroxetine in adolescents with unipolar major depression. Poster presented at the 46th annual meeting of the American Academy of Child and Adolescent Psychiatry in Chicago, IL, 19-24 October. Scientific Proceedings.
  • PFEFFER, C.R., JIANG, H. & DOMESHEK, L.J. (1997). Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression. Journal of Chad and Adolescent Psychopharmacology, 7, 145-155.
  • PERRIN, S. & LAST, G.G. (1992). Do childhood anxiety measures measure anxiety? Journal of Abnormal Child Psychology, 20, 567-578.
  • PINE, D., KLEIN, R.G., COPLAN, J.D., et al (2000). Differential carbon-dioxide sensitivity in childhood anxiety disorders and normal comparison group. Archives of General Psychiatry, 57, 960-967.
  • PINE, D.S. & GRUN, J. (1998). Anxiety disorders. In: T.B. WALSH (Ed.), Child psychopharmacology. Review of psychiatry series (pp. 115-148). Washington, DC: American Psychiatric Press.
  • PINE, D.S., COHEN, P., GURLEY, D., BROOK, J. & MA, Y. (1998). The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Archives of General Psychiatry, 55, 56-64.
  • POZNANSKI, E.O. & MOKROS, H.B. (1995). Children's Depression Rating Scale, Revised (CDRS-R). Los Angeles, CA: Western Psychological Services.
  • RAPOPORT, J., CONNERS, C.K. & REATIG, N. (Eds) (1985). Clinical Global Impression (CGI) Scale. Psychopharmacology Bulletin, 21, 839-843.
  • RAPEE, R.M., BARRET, P.M., DADDS, M.R. & EVANS, L. (1994). Reliability of the DSM-III-R childhood anxiety disorders using structured interview: interrater and parent-child agreement. Journal of American Academy of Child and Adolescent Psychiatry, 33, 984-992.
  • RIDDLE, M.R., SUBRAMANIUM, G. & WALKUP, J.T. (1998). Efficacy of psychiatric medications in children and adolescents: a review of controlled studies. Psychiatric Clinic of North America (Annual Drug Therapy), 5, 269-285.
  • RIDDLE, M.R., REEVE, E.A., YARYURA-TOBIAS, J.A., et al (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder a randomized, controlled, multicenter trial. Journal of American Academy of Child and Adolescent Psychiatry, 40, 222-229.
  • RESEARCH UNITS FOR PEDIATRIC PSYCHOPHARMACOLOGY (RUPP) ANXIETY STUDY GROUP (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine, 344, 1279-1285.
  • RONAN, K. (1996). Building a reasonable bridge in childhood anxiety assessment: a practitioners resource guide. Cognitive Behavior Practice, 3, 63-90.
  • RYAN, N.D. & PUIG-ANTICH, J. (1987). Pharmacological treatment of adolescent psychiatric disorders. Journal of Adolescent Health Care, 8, 137-142
  • RYAN, N.D., PUIG-ANTICH, J., COOPER, T., RABINOVICH, H., AMBROSINI, P., DAVIES, M., KING, J., TORRES, D. & FRIED, J. (1986). Imipramine in adolescent major depression: plasma level and clinical response. Acta Psychiatrica Scandinavica 73, 275-288.
  • RYNN, M.A., SIQUELAND, L. & RICKELS, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. American Journal of Psychiatry, 158(12), 2008-2014.
  • SCAHILL, L., RIDDLE, M.A., MCSWIGGIN-HARDIN, M., et al (1997a) Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. Journal of American Academy of Child and Adolescent Psychiatry, 36, 844-S52.
  • SCAHILL, L., RIDDLE, M.A., KING, R.A., HARDIN, M.T., RASMUSSON, A., MAKUCH, R.W., LECKMAN, J.F. (1997b). Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double blind placebo controlled study. Journal of Child and Adolescent Psychopharmacology, 7, 75-85.
  • SILVERMAN, W.K. & EISEN, A.R. (1992). Age differences in the reliability of parent and child reports of child anxious symptomatology using a structured interview. Journal of American Academy of Child and Adolescent Psychiatry, 31, 117-124.
  • SILVERMAN, W.K. & KURTINES, W.K. (1996). Childhood anxiety and phobic disorders: a pragmatic perspective. New York Plenum Press.
  • SILVERMAN, W.K. & NELLES, W.B. (1988). The Anxiety Disorders Interview Schedule for Children. Journal of American Academy of Child and Adolescent Psychiatry, 27, 772-778.
  • SILVERMAN, W.K. & RABIAN, B. (1995). Test-retest reliability of the DSM-III-R anxiety childhood disorders symptoms using the Anxiety Disorders Interview Schedule for Children. Journal of Anxiety Disorder, 9, 1-12.
  • SlLVERMAN, W.K., ALBANO, A. & BARLOW, D. (1999). The anxiety disorder interview schedule for children for DSM-IV (ADIS-C/P-IV). New York: Psychological Corporation.
  • SlLVERMAN, W.K., GlNSBURG, G.S. & KURTINES, W.M. (1995). Clinical issues in treating children with anxiety and phobic disorders. Cognitive Behavior Practice, 2, 93-117.
  • SlLVERMAN, W.K., KURTINES, W.M., GlNSBURG, G.S., WEEMS, C.F., LUMPKIN, P.W. & CARMICHAEL, D.H. (1999a). Treating anxiety disorders in children with group cognitive behavior therapy: a randomized clinical trial. Journal of Consulting Clinical Psychology, 67, 995-1003.
  • SlLVERMAN, W.K., KURTINES, W.M., GlNSBURG, G.S., WEEMS, C-F., RABIAN, B. & SERAFINI, L.T (1999b). Contingency management, self-control, and education support in the treatment of childhood phobic disorders: a randomized clinical trial. Journal of Consulting Clinical Psychology, 67, 675-687.
  • SPENCE, S.H., DONOVAN, C. & BRECHMAN-TOUSSAINT, M. (2000). The treatment of childhood social phobia: the effectiveness of a social skills training-based, cognitivebehavioral intervention, with and without parental involvement. Journal of Chad Psychology Psychiatry Allied Disciplines, 41, 713-726.
  • SIMEON, J.G. & FERGUSON, H.B. (1987). Alprazolam effects in children with anxiety disorders. Canadian Journal of Psychiatry, 32, 570-574.
  • SIMEON, J.G., FERGUSON, H.B., KNOTT, V., ROBERTS, N., GAUTHIER, B., DUBOIS, C. & WIGGINS, D. (1992). Clinical, cognitive, and neurophysiological effects of alprazolam in children andadolescents with overanxious and avoidant disorders. Journal of American Academy of Child and Adolescent Psychiatry, 31, 29-33.
  • SIMEON, J.G., KNOTT, V.J., DUBOIS, C., WIGGINS, D., GERAETS, I., THATTE, S. & MILLER, W. (1994). Buspirone therapy of mixed anxiety disorders in childhood and adolescence: a pilot study. Journal of Chad and Adolescent Psychopharmacology, 4, 159-170.
  • SPENCER, T., BIEDERMAN, J. & WILENS, T. (2000). Pharmacotherapy of attention deficit hyperactivity disorder. Chad and Adolescent Psychiatric Clinic of North America, 9(1), 77-97.
  • STEIN, M.B., SAREEN, J., HAMI, S. & CHAO, J. (2001) Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study. American Journal of Psychiatry, 158(10), 1725-1727.
  • UHDE, T.W., STEIN, M.B., SIEVER, L.J., et al (1989). Behavioraland physiological effects of short-term and long-term administration of clonidine in panic disorder. Archives of General Psychiatry, 46, 353,
  • VAN AMERIGEN, M.V., MANCINI, C. & OAKMAN, J.M. (1999). Nefazodone in social phobia. Journal of Clinical Psychiatry, 60, 96-1000.
  • WAGNER, K., BIRMAHER, B., CARLSON, G., et al (1998) Multicenter trial of paroxetine and imipramine in the treatment of adolescent depression. Poster presented at the 45th annual meeting of the American Academy of Child and Adolescent Psychiatry in Anaheim, CA, 27 October-1 November. Scientific Proceedings.
  • WALKUP, J. (1999). The Pediatric Anxiety Rating Scale (PARS): a reliability study. Poster presented at the 46th annual meeting of the American Academy of Child and Adolescent Psychiatry, New York, 19-24 October. Scientific Proceedings
  • WARMAN, A. (1997). Therapy for youths with anxiety disorders: a second randomized clinical trial. Journal of Consulting Clinical Psychology, 65, 366-380.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.